Mylan to Acquire King for US$4 B
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 52 (Table of Contents)
Published: 4 Oct-2004
DOI: 10.3833/pdr.v2004.i52.774 ISSN: 1756-7874
Section: Mergers & Acquisitions
Abstract
Mylan Laboratories entered into an agreement to acquire King Pharmaceuticals thus substantially expanding its pharmaceutical product portfolio...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Last Issue PDF
RSS